Curcumin Analog DK1 Induces Apoptosis in Human Osteosarcoma Cells In Vitro through Mitochondria-Dependent Signaling Pathway

Muhammad Nazirul Mubin Aziz, Yazmin Hussin, Nurul Fattin Che Rahim, Noraini Nordin, Nurul Elyani Mohamad, Swee Keong Yeap, Chean Yeah Yong, Mas Jaffri Masarudin, Yoke Kqueen Cheah, Nadiah Abu, Muhammad Nadeem Akhtar, Noorjahan Banu Alitheen

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Osteosarcoma is one of the primary malignant bone tumors that confer low survival rates for patients even with intensive regime treatments. Therefore, discovery of novel anti-osteosarcoma drugs derived from natural products that are not harmful to the normal cells remains crucial. Curcumin is one of the natural substances that have been extensively studied due to its anti-cancer properties and is pharmacologically safe considering its ubiquitous consumption for centuries. However, curcumin suffers from a poor circulating bioavailability, which has led to the development of a chemically synthesized curcuminoid analog, namely (Z)-3-hydroxy-1-(2-hydroxyphenyl)-3-phenylprop-2-en-1-one (DK1). In this study, the cytotoxic effects of the curcumin analog DK1 was investigated in both U-2OS and MG-63 osteosarcoma cell lines using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and cell death was microscopically examined via acridine orange/propidium iodide (AO/PI) double staining. Flow cytometer analysis including Annexin V/Fluorescein isothiocyanate (FITC), cell cycle analysis and JC-1 were adapted to determine the mode of cell death. Subsequently in order to determine the mechanism of cell death, quantitative polymerase chain reaction (qPCR) and proteome profiling was carried out to measure the expression of several apoptotic-related genes and proteins. Results indicated that DK1 induced U-2 OS and MG-63 morphological changes and substantially reduced cell numbers through induction of apoptosis. Several apoptotic genes and proteins were steadily expressed after treatment with DK1; including caspase 3, caspase 9, and BAX, which indicated that apoptosis occurred through a mitochondria-dependent signaling pathway. In conclusion, DK1 could be considered as a potential candidate for an anti-osteosarcoma drug in the near future, contingent upon its ability to induce apoptosis in osteosarcoma cell lines.

Original languageEnglish
Article number75
JournalMolecules
Volume23
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018

Fingerprint

Mitochondria
Curcumin
mitochondria
apoptosis
Cell death
Osteosarcoma
Cells
death
analogs
Apoptosis
cells
cultured cells
Cell Death
genes
Acridine Orange
drugs
Caspase 9
Propidium
Annexin A5
Polymerase chain reaction

Keywords

  • Curcumin analog DK1
  • Human osteosarcoma U-2OS
  • MG-63

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Aziz, M. N. M., Hussin, Y., Rahim, N. F. C., Nordin, N., Mohamad, N. E., Yeap, S. K., ... Alitheen, N. B. (2018). Curcumin Analog DK1 Induces Apoptosis in Human Osteosarcoma Cells In Vitro through Mitochondria-Dependent Signaling Pathway. Molecules, 23(1), [75]. https://doi.org/10.3390/molecules23010075

Curcumin Analog DK1 Induces Apoptosis in Human Osteosarcoma Cells In Vitro through Mitochondria-Dependent Signaling Pathway. / Aziz, Muhammad Nazirul Mubin; Hussin, Yazmin; Rahim, Nurul Fattin Che; Nordin, Noraini; Mohamad, Nurul Elyani; Yeap, Swee Keong; Yong, Chean Yeah; Masarudin, Mas Jaffri; Cheah, Yoke Kqueen; Abu, Nadiah; Akhtar, Muhammad Nadeem; Alitheen, Noorjahan Banu.

In: Molecules, Vol. 23, No. 1, 75, 01.01.2018.

Research output: Contribution to journalArticle

Aziz, MNM, Hussin, Y, Rahim, NFC, Nordin, N, Mohamad, NE, Yeap, SK, Yong, CY, Masarudin, MJ, Cheah, YK, Abu, N, Akhtar, MN & Alitheen, NB 2018, 'Curcumin Analog DK1 Induces Apoptosis in Human Osteosarcoma Cells In Vitro through Mitochondria-Dependent Signaling Pathway', Molecules, vol. 23, no. 1, 75. https://doi.org/10.3390/molecules23010075
Aziz, Muhammad Nazirul Mubin ; Hussin, Yazmin ; Rahim, Nurul Fattin Che ; Nordin, Noraini ; Mohamad, Nurul Elyani ; Yeap, Swee Keong ; Yong, Chean Yeah ; Masarudin, Mas Jaffri ; Cheah, Yoke Kqueen ; Abu, Nadiah ; Akhtar, Muhammad Nadeem ; Alitheen, Noorjahan Banu. / Curcumin Analog DK1 Induces Apoptosis in Human Osteosarcoma Cells In Vitro through Mitochondria-Dependent Signaling Pathway. In: Molecules. 2018 ; Vol. 23, No. 1.
@article{54fe6302eb9446f5ab951081cc314c28,
title = "Curcumin Analog DK1 Induces Apoptosis in Human Osteosarcoma Cells In Vitro through Mitochondria-Dependent Signaling Pathway",
abstract = "Osteosarcoma is one of the primary malignant bone tumors that confer low survival rates for patients even with intensive regime treatments. Therefore, discovery of novel anti-osteosarcoma drugs derived from natural products that are not harmful to the normal cells remains crucial. Curcumin is one of the natural substances that have been extensively studied due to its anti-cancer properties and is pharmacologically safe considering its ubiquitous consumption for centuries. However, curcumin suffers from a poor circulating bioavailability, which has led to the development of a chemically synthesized curcuminoid analog, namely (Z)-3-hydroxy-1-(2-hydroxyphenyl)-3-phenylprop-2-en-1-one (DK1). In this study, the cytotoxic effects of the curcumin analog DK1 was investigated in both U-2OS and MG-63 osteosarcoma cell lines using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and cell death was microscopically examined via acridine orange/propidium iodide (AO/PI) double staining. Flow cytometer analysis including Annexin V/Fluorescein isothiocyanate (FITC), cell cycle analysis and JC-1 were adapted to determine the mode of cell death. Subsequently in order to determine the mechanism of cell death, quantitative polymerase chain reaction (qPCR) and proteome profiling was carried out to measure the expression of several apoptotic-related genes and proteins. Results indicated that DK1 induced U-2 OS and MG-63 morphological changes and substantially reduced cell numbers through induction of apoptosis. Several apoptotic genes and proteins were steadily expressed after treatment with DK1; including caspase 3, caspase 9, and BAX, which indicated that apoptosis occurred through a mitochondria-dependent signaling pathway. In conclusion, DK1 could be considered as a potential candidate for an anti-osteosarcoma drug in the near future, contingent upon its ability to induce apoptosis in osteosarcoma cell lines.",
keywords = "Curcumin analog DK1, Human osteosarcoma U-2OS, MG-63",
author = "Aziz, {Muhammad Nazirul Mubin} and Yazmin Hussin and Rahim, {Nurul Fattin Che} and Noraini Nordin and Mohamad, {Nurul Elyani} and Yeap, {Swee Keong} and Yong, {Chean Yeah} and Masarudin, {Mas Jaffri} and Cheah, {Yoke Kqueen} and Nadiah Abu and Akhtar, {Muhammad Nadeem} and Alitheen, {Noorjahan Banu}",
year = "2018",
month = "1",
day = "1",
doi = "10.3390/molecules23010075",
language = "English",
volume = "23",
journal = "Molecules",
issn = "1420-3049",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "1",

}

TY - JOUR

T1 - Curcumin Analog DK1 Induces Apoptosis in Human Osteosarcoma Cells In Vitro through Mitochondria-Dependent Signaling Pathway

AU - Aziz, Muhammad Nazirul Mubin

AU - Hussin, Yazmin

AU - Rahim, Nurul Fattin Che

AU - Nordin, Noraini

AU - Mohamad, Nurul Elyani

AU - Yeap, Swee Keong

AU - Yong, Chean Yeah

AU - Masarudin, Mas Jaffri

AU - Cheah, Yoke Kqueen

AU - Abu, Nadiah

AU - Akhtar, Muhammad Nadeem

AU - Alitheen, Noorjahan Banu

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Osteosarcoma is one of the primary malignant bone tumors that confer low survival rates for patients even with intensive regime treatments. Therefore, discovery of novel anti-osteosarcoma drugs derived from natural products that are not harmful to the normal cells remains crucial. Curcumin is one of the natural substances that have been extensively studied due to its anti-cancer properties and is pharmacologically safe considering its ubiquitous consumption for centuries. However, curcumin suffers from a poor circulating bioavailability, which has led to the development of a chemically synthesized curcuminoid analog, namely (Z)-3-hydroxy-1-(2-hydroxyphenyl)-3-phenylprop-2-en-1-one (DK1). In this study, the cytotoxic effects of the curcumin analog DK1 was investigated in both U-2OS and MG-63 osteosarcoma cell lines using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and cell death was microscopically examined via acridine orange/propidium iodide (AO/PI) double staining. Flow cytometer analysis including Annexin V/Fluorescein isothiocyanate (FITC), cell cycle analysis and JC-1 were adapted to determine the mode of cell death. Subsequently in order to determine the mechanism of cell death, quantitative polymerase chain reaction (qPCR) and proteome profiling was carried out to measure the expression of several apoptotic-related genes and proteins. Results indicated that DK1 induced U-2 OS and MG-63 morphological changes and substantially reduced cell numbers through induction of apoptosis. Several apoptotic genes and proteins were steadily expressed after treatment with DK1; including caspase 3, caspase 9, and BAX, which indicated that apoptosis occurred through a mitochondria-dependent signaling pathway. In conclusion, DK1 could be considered as a potential candidate for an anti-osteosarcoma drug in the near future, contingent upon its ability to induce apoptosis in osteosarcoma cell lines.

AB - Osteosarcoma is one of the primary malignant bone tumors that confer low survival rates for patients even with intensive regime treatments. Therefore, discovery of novel anti-osteosarcoma drugs derived from natural products that are not harmful to the normal cells remains crucial. Curcumin is one of the natural substances that have been extensively studied due to its anti-cancer properties and is pharmacologically safe considering its ubiquitous consumption for centuries. However, curcumin suffers from a poor circulating bioavailability, which has led to the development of a chemically synthesized curcuminoid analog, namely (Z)-3-hydroxy-1-(2-hydroxyphenyl)-3-phenylprop-2-en-1-one (DK1). In this study, the cytotoxic effects of the curcumin analog DK1 was investigated in both U-2OS and MG-63 osteosarcoma cell lines using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and cell death was microscopically examined via acridine orange/propidium iodide (AO/PI) double staining. Flow cytometer analysis including Annexin V/Fluorescein isothiocyanate (FITC), cell cycle analysis and JC-1 were adapted to determine the mode of cell death. Subsequently in order to determine the mechanism of cell death, quantitative polymerase chain reaction (qPCR) and proteome profiling was carried out to measure the expression of several apoptotic-related genes and proteins. Results indicated that DK1 induced U-2 OS and MG-63 morphological changes and substantially reduced cell numbers through induction of apoptosis. Several apoptotic genes and proteins were steadily expressed after treatment with DK1; including caspase 3, caspase 9, and BAX, which indicated that apoptosis occurred through a mitochondria-dependent signaling pathway. In conclusion, DK1 could be considered as a potential candidate for an anti-osteosarcoma drug in the near future, contingent upon its ability to induce apoptosis in osteosarcoma cell lines.

KW - Curcumin analog DK1

KW - Human osteosarcoma U-2OS

KW - MG-63

UR - http://www.scopus.com/inward/record.url?scp=85040576290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040576290&partnerID=8YFLogxK

U2 - 10.3390/molecules23010075

DO - 10.3390/molecules23010075

M3 - Article

VL - 23

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 1

M1 - 75

ER -